Who owns the NEOMAB BIO trademark?

The NEOMAB BIO trademark is owned by GemPharmatech Co., Ltd..

What class is the NEOMAB BIO trademark registered in?

The NEOMAB BIO trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for NEOMAB BIO?

The USPTO serial number for NEOMAB BIO is 98394125.

What is the registration number for NEOMAB BIO?

NEOMAB BIO is registered under USPTO registration number 7896288.

Sealvo

Home Search: NEOMAB BIONEOMAB BIO #98394125

Back

Updated Sep 19, 2026·42 searches this week

View on USPTO TSDR Find similar marks

NEO

USPTO Trademark Record

REGISTERED

NEOMAB BIO

SN 98394125·Reg 7896288·Filed Feb 06, 2024

Owner GemPharmatech Co., Ltd.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

NEOMAB BIO (Serial No. 98394125), Registration No. 7896288, is a registered US trademark filed on Feb 06, 2024 by GemPharmatech Co., Ltd.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: August 19, 2031

Conflict Analysis

Full conflict analysis for NEOMAB BIO (SN 98394125) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

NEOMAB BIO (Reg. #7896288) is a registered US trademark that has been protecting its owner, GemPharmatech Co., Ltd., since 2024. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 06, 2024

SERIAL

98394125

REG#

7896288

REGISTERED

Aug 19, 2025

Filing Information

StatusREGISTERED

Filing DateFeb 06, 2024

Serial Number98394125

Registration No.7896288

Registration DateAug 19, 2025

Status DateAug 19, 2025

Published for OppositionJun 03, 2025

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

22 events

REGISTERED-PRINCIPAL REGISTER

Aug 19, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 19, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jun 03, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 03, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 28, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

May 01, 2025

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 01, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 01, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 01, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Apr 17, 2025

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

SUSPENSION LETTER WRITTEN

Nov 04, 2024

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Nov 04, 2024

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Nov 04, 2024

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 01, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 01, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 01, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO EXAMINER

Aug 29, 2024

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Aug 29, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 29, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 29, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 04, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 06, 2024

NEW APPLICATION ENTERED

Other Marks by GemPharmatech Co., Ltd.

Additional USPTO filings from the same owner.

LOG

LogoMark

98393886

GemPharmatech Co., Ltd.

REGISTERED

NEO

NEOMAB-CLC

98563302

GemPharmatech Co., Ltd.

REGISTERED

NEO

NEOMAB-HC

98573194

GemPharmatech Co., Ltd.

REGISTERED

NEO

NEOMAB BIO

98393993

GemPharmatech Co., Ltd.

REGISTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

NEO

NEOMAB

98417072

GemPharmatech Co., Ltd.

REGISTERED

NEO

NEOMAB-CLC

98563302

GemPharmatech Co., Ltd.

REGISTERED

NEO

NEOMAB-HC

98573194

GemPharmatech Co., Ltd.

REGISTERED

BIO

74417840

BIOTECHNOLOGY INNOVATION ORGANIZATION

REGISTERED

Other Marks by Nazly Aileen Bayramoglu

Additional USPTO filings handled by the same attorney of record.

SOV

SOVI

99611800

REGISTERED

ARX

ARXUS

98719937

REGISTERED

ARX

ARXUS

98720057

REGISTERED

CHE

CHEF NAK

98794980

REGISTERED

NEOMAB BIO

Run a conflict check

Other Marks by GemPharmatech Co., Ltd.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Nazly Aileen Bayramoglu

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company